This research identified that use of GLP-1 agonists for weight loss in contrast with usage of bupropion-naltrexone was linked to elevated possibility of pancreatitis, gastroparesis, and bowel obstruction but not biliary disease. It may differ. Some individuals may have side effects from Wegovy, a